This review provides a framework for more robust assessment of clinicopathological associations of neuropsychological abnormalities in ALS in the future, advocating for greater utilization of pre‐symptomatic C9orf72 repeat expansion‐carrying cohorts. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.